We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Peptide Mimics as a Drug Target for Ebola

News   Oct 18, 2014

 
Peptide Mimics as a Drug Target for Ebola
 
 
 

RELATED ARTICLES

3D Electron Microscopy of Synapse Building

News

Using a technique called 3D electron microscopy, the authors determined that calcium channel α2δ-1 subunit promotes proper synapse development and structure.

READ MORE

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News

Dr. Carl Ascoli, Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, have composed a review article on the pros and cons of polyclonal, conventional monoclonal, and recombinant monoclonal antibodies.

READ MORE

A Powerful Approach for Stopping Ebola Outbreaks

News

A one-two punch of powerful antibodies may be the best way to stop Ebola virus. Recent findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE